Phenylbutyrate in Proteinuric Nephropathies

NCT02343094 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Proteinuric Diseases

Interventions

DRUG: PBA 7,5g/d
DRUG: PBA 15g/d

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]